跳至主要内容
临床试验/JPRN-UMIN000018192
JPRN-UMIN000018192已完成未知

A prospective, multi-center, single-arm study of tOCP/Col for guided bone regeneration - A prospective, multi-center, single-arm study of OCP/Col

TOYOBO CO., LTD.0 个研究点目标入组 60 人开始时间: 2015年7月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
7years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patient suffering severe hepatopathy, renal disorders, and heart disease who would affect safety evaluation of this trial. Patient who has an allergy drug. Patient who has a bone metabolism disease like osteoporosis or has a medication of bisphosphonate. Patient who has a medication of steroid or immunosuppressant (The local administration is excluded). Patient who receives an anticoagulant therapy. Patient who is pregnant, possibly pregnant, nursing or considering pregnancy. Patient who has an uncontroled diabetes. Smoker, but the patient who was able to confirm intention of the smoking cessation before clinical trial participation is excluded. Patient who participated other clinical trial program within 3 months prior to the study entry Others, patient who is unfit for the study as determined by the principal investigator or sub-investigators

研究者

相似试验